Shandong Weigao Medical Polymer Profit Margin 2012-2024 | SHWGF
Current and historical gross margin, operating margin and net profit margin for Shandong Weigao Medical Polymer (SHWGF) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Shandong Weigao Medical Polymer net profit margin as of June 30, 2024 is 0%.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.120B | $1.821B |
| Shandong Weigao Group Medical Polymer Company Limited is engaged in the research and development, production, and sale of single-use medical devices. Single use products offered by the Company includes syringes, blood bags and blood component segregator consumables, blood sampling products, dental and anesthetic consumables, and prefilled syringes for pre-pack medication and etc. It also offers orthopedic materials and instruments like trauma products of steel plates and screws, spinal implants, and artificial joints; blood purification consumables, such as puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers, PVC granules, and related consumables, as well as immunity adsorption products for the treatment of immune system diseases; and cardiovascular stents, including drug eluting stents and balloons. Shandong Weigao Group Medical Polymer Company is based in Weihai, the People's Republic of China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $216.559B | 24.96 |
| EssilorLuxottica (ESLOY) | France | $168.705B | 0.00 |
| Boston Scientific (BSX) | United States | $146.614B | 33.53 |
| Stryker (SYK) | United States | $136.781B | 27.16 |
| Medtronic (MDT) | Ireland | $115.955B | 16.35 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.709B | 0.00 |
| Agilent Technologies (A) | United States | $41.609B | 26.93 |
| ResMed (RMD) | United States | $35.788B | 24.77 |
| GE HealthCare Technologies (GEHC) | United States | $34.442B | 16.47 |
| Koninklijke Philips (PHG) | Netherlands | $27.029B | 17.65 |
| Terumo (TRUMY) | Japan | $24.148B | 28.61 |
| Insulet (PODD) | United States | $22.134B | 74.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.343B | 10.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.690B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.495B | 0.00 |
| Baxter (BAX) | United States | $9.227B | 7.45 |
| Bio-Rad Laboratories (BIO) | United States | $8.390B | 30.07 |
| Demant (WILYY) | Denmark | $7.359B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.891B | 10.52 |
| Envista Holdings (NVST) | United States | $3.313B | 19.01 |
| ICU Medical (ICUI) | United States | $3.144B | 21.41 |
| Prestige Consumer Healthcare (PBH) | United States | $2.944B | 13.06 |
| Haemonetics (HAE) | United States | $2.444B | 10.91 |
| Perrigo (PRGO) | Ireland | $2.078B | 5.21 |
| LeMaitre Vascular (LMAT) | United States | $1.953B | 41.88 |
| Curaleaf Holdings (CURLF) | Canada | $1.917B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.858B | 11.95 |
| Phibro Animal Health (PAHC) | United States | $1.668B | 16.66 |
| AtriCure (ATRC) | United States | $1.607B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.437B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.421B | 62.27 |
| AdaptHealth (AHCO) | United States | $1.399B | 20.27 |
| Kestra Medical Technologies (KMTS) | United States | $1.363B | 0.00 |
| Neogen (NEOG) | United States | $1.349B | 25.88 |
| BioLife Solutions (BLFS) | United States | $1.321B | 2757.00 |
| InMode (INMD) | Israel | $0.918B | 10.38 |
| Valneva SE (VALN) | France | $0.774B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.492B | 16.94 |
| SNDL (SNDL) | Canada | $0.486B | 0.00 |
| Omeros (OMER) | United States | $0.476B | 0.00 |
| Evolus (EOLS) | United States | $0.441B | 0.00 |
| CeriBell (CBLL) | United States | $0.437B | 0.00 |
| Surmodics (SRDX) | United States | $0.394B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.384B | 0.00 |
| Brainsway (BWAY) | Israel | $0.307B | 62.19 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.284B | 0.00 |
| Cerus (CERS) | United States | $0.278B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.273B | 0.00 |
| High Tide (HITI) | Canada | $0.263B | 0.00 |
| Owens & Minor (OMI) | United States | $0.259B | 2.60 |
| Aurora Cannabis (ACB) | Canada | $0.251B | 148.67 |
| Viemed Healthcare (VMD) | United States | $0.249B | 19.49 |
| Sanara MedTech (SMTI) | United States | $0.246B | 0.00 |
| Quanterix (QTRX) | United States | $0.240B | 0.00 |
| Exagen (XGN) | United States | $0.234B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.222B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.210B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.195B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 16.38 |
| FitLife Brands (FTLF) | United States | $0.184B | 22.66 |
| Biote (BTMD) | United States | $0.145B | 5.86 |
| Sharps Technology (STSS) | United States | $0.119B | 0.00 |
| Apyx Medical (APYX) | United States | $0.119B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.99 |
| MacroGenics (MGNX) | United States | $0.091B | 0.00 |
| Agape ATP (ATPC) | $0.061B | 0.00 | |
| Nephros (NEPH) | United States | $0.060B | 47.42 |
| ImmuCell (ICCC) | United States | $0.057B | 33.16 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Jin Medical (ZJYL) | China | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Bonk (BNKK) | United States | $0.036B | 0.00 |
| Zynex (ZYXI) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.032B | 12.50 |
| Modular Medical (MODD) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| INLIF (INLF) | China | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |